- $754.41m
- $13.51bn
- $759.58m
- 16
- 94
- 13
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 622 | 572 | 575 | 708 | 760 |
Cost of Revenue | |||||
Gross Profit | 142 | 124 | 148 | 148 | 113 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 446 | 1,158 | 237 | 891 | 760 |
Operating Profit | 177 | -586 | 338 | -183 | -0.639 |
Net Income Before Taxes | 177 | -586 | 338 | -183 | -0.639 |
Provision for Income Taxes | |||||
Net Income After Taxes | 169 | -582 | 320 | -164 | -2.27 |
Net Income Before Extraordinary Items | |||||
Net Income | 169 | -582 | 320 | -164 | -2.27 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 164 | -584 | 337 | -168 | -13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.25 | -4.53 | 2.51 | -1.37 | -0.06 |
Dividends per Share |